KLBF - Around 7% yoy sales growth in 2024

KLBF - Around 7% yoy sales growth in 2024 Kalbe Farma (KLBF) expects around 7% yoy sales growth this year, which the company has achieved in 1H24. KLBF posted revenue of IDR16.33 tn (+7.57% yoy) and net profit of IDR1.81 tn (+18.06% yoy) in 1H24. KLBF will continue to drive sales of prescription drugs and medical devices for business growth. KLBF also pioneered a cyclotron business that is able to detect cancer early. (Source : Kontan)